Crohn Disease

Vedolizumab Shows Long-Term Efficacy and Safety Data in Patients With Active UC and CD

The following article is a part of conference coverage from the 2019 Advances in Inflammatory Bowel Diseases (AIBD) Meeting, being held in Orlando, Florida. The team at MPR will be reporting on the latest news and research conducted by leading experts gastroenterology. Check back for more from the 2019 AIBD Meeting. ORLANDO – Vedolizumab demonstrated…